PLoS ONE (Jan 2018)

Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: Evidences from the National NCDs STEPS Survey, 2015.

  • Yeweyenhareg Feleke Gebreyes,
  • Dejuma Yadeta Goshu,
  • Tedla Kebede Geletew,
  • Terefe Gelibo Argefa,
  • Theodros Getachew Zemedu,
  • Kassahun Amenu Lemu,
  • Feyissa Challa Waka,
  • Alemayehu Bekele Mengesha,
  • Fasil Shiferaw Degefu,
  • Atkure Defar Deghebo,
  • Habtamu Teklie Wubie,
  • Mussie Gebremichael Negeri,
  • Tefera Tadele Tesema,
  • Yabetse Girma Tessema,
  • Mulugeta Guta Regassa,
  • Geremew Gonfa Eba,
  • Misrak Getnet Beyene,
  • Kissi Mudie Yesu,
  • Girum Taye Zeleke,
  • Yewondwossen Tadesse Mengistu,
  • Abebe Bekele Belayneh

DOI
https://doi.org/10.1371/journal.pone.0194819
Journal volume & issue
Vol. 13, no. 5
p. e0194819

Abstract

Read online

The prevalence of diabetes, dyslipidemias, and high blood pressure is increasing worldwide especially in low and middle income countries. World Health Organization has emphasized the importance of the assessment of the magnitude of the specific disease in each country. We determined the prevalence and determinant factors of high blood pressure, hyperglycemia, dyslipidemias and metabolic syndrome in Ethiopia. A community based survey was conducted from -April to June 2015 using WHO NCD STEPS instrument version 3.1. 2008. Multistage stratified systemic random sampling was used to select representative samples from 9 regions of the country. A total of 10,260 people aged 15-69 years participated in the study. Blood pressure (BP) was measured for 9788 individuals. A total of 9141 people underwent metabolic screening. The prevalence of raised blood pressure (SBP ≥140 and/or DBP ≥ 90 mmHg) was 15.8% (16.3% in females and 15.5% in males). The prevalence of diabetes mellitus (FBS ≥ 126 mg /dl) including those on medication was 3.2% (3.5% males and 3.0% females). The prevalence of impaired fasting glucose was 9.1% with ADA criteria and 3.8% with WHO criteria. Hypercholesterolemia was found in 5.2%, hypertriglyceridemia in 21.0%, high LDL cholesterol occurred in 14.1% and low HDL cholesterol occurred in 68.7%. The prevalence of metabolic syndrome using IDF definition was 4.8% (8.6% in females and vs. 1.8% in males). Advanced age, urban residence, lack of physical exercise, raised waist circumference, raised waist hip ratio, overweight or obesity, and total blood cholesterol were significantly associated with raised blood pressure (BP) and diabetes mellitus. Increased waist- hip ratio was an independent predictor of raised blood pressure, hyperglycemia and raised total cholesterol. Our study showed significantly high prevalence of raised blood pressure, hyperglycemia and dyslipidemia in Ethiopia. Community based interventions are recommended to control these risk factors.